Crizanlizumab approved in Europe for Prevention of recurrent vaso-occlusive Crises in Sickle Cell Disease

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [1] Crizanlizumab for the Prevention of Vaso-Occlusive Pain Crises in Sickle Cell Disease
    Stevens, Debra L.
    Hix, Meri
    Gildon, Brooke L.
    JOURNAL OF PHARMACY TECHNOLOGY, 2021, 37 (04) : 209 - 215
  • [2] The European Medicines Agency Review of Crizanlizumab for the Prevention of Recurrent Vaso-Occlusive Crises in Patients With Sickle Cell Disease
    Delgado, Julio
    Voltz, Caroline
    Stain, Milena
    Lapvetelainen, Tuomo
    Urach, Susanne
    Lahteenvuo, Johanna
    Penttila, Karri
    Gisselbrecht, Christian
    Enzmann, Harald
    Pignatti, Francesco
    HEMASPHERE, 2021, 5 (07): : E604
  • [3] Crizanlizumab in vaso-occlusive crisis caused by sickle cell disease
    Gardner, R., V
    DRUGS OF TODAY, 2020, 56 (11) : 705 - 714
  • [4] Sickle Cell Disease and Pain Is it all Vaso-occlusive Crises?
    Ramsay, Zachary
    Bartlett, Rachel
    Ali, Amza
    Grant, Justin
    Gordon-Strachan, Georgiana
    Asnani, Monika
    CLINICAL JOURNAL OF PAIN, 2021, 37 (08): : 583 - 590
  • [5] Sickle cell disease in children: Osteomyelitis or vaso-occlusive crises?
    Berger, Elizabeth
    Saunders, Natasha
    Khambalia, Amina
    Friedman, Jeremy N.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 612 - 612
  • [6] P-Selectin Blockade in the Treatment of Painful Vaso-Occlusive Crises in Sickle Cell Disease: A Spotlight on Crizanlizumab
    Karki, Nabin Raj
    Kutlar, Abdullah
    JOURNAL OF PAIN RESEARCH, 2021, 14 : 849 - 856
  • [7] Contemporary Management and Prevention of Vaso-Occlusive Crises (VOCs) in Adults With Sickle Cell Disease
    Weaver, Salome Bwayo
    Rungkitwattanakul, Dhakrit
    Singh, Divita
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (01) : 139 - 148
  • [8] BMI AND THE ASSOCIATION WITH VASO-OCCLUSIVE CRISES IN PEDIATRIC SICKLE CELL DISEASE
    Zivot, Andrea
    Apollonsky, Nataly
    Raybagkar, Deepti
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 55 - 55
  • [9] Clinical complications among patients with sickle cell disease with recurrent vaso-occlusive crises in Germany
    Tuzin, P.
    Udeze, C.
    Kunzweiler, C.
    Li, N.
    Baldwin, J.
    Barth, S. D.
    Vetter, C.
    Dombrowski, S.
    Georgiadou-Schmidt, E.
    Meisel, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 300 - 301
  • [10] Real-World Evidence of Crizanlizumab Showing Reductions in Vaso-Occlusive Crises and Opioid Usage in Sickle Cell Disease
    DeBonnett, Laurie
    Joshi, Vikas
    Silva-Pinto, Ana Cristina
    Colombatti, Raffaella
    Pasanisi, Annamaria
    Arcioni, Francesco
    Cancado, Rodolfo D.
    Sarp, Severine
    Sarkar, Rajendra
    Soliman, Wesam
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (02) : 293 - 302